JN Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 99: 1285-1293, 2008. First published January 23, 2008; doi:10.1152/jn.01180.2007
0022-3077/08 $8.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
99/3/1285    most recent
01180.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feng, H.-J.
Right arrow Articles by Macdonald, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feng, H.-J.
Right arrow Articles by Macdonald, R. L.

Alterations of GABAA-Receptor Function and Allosteric Modulation During Development of Status Epilepticus

Hua-Jun Feng1, Gregory C. Mathews1,3, Chris Kao4 and Robert L. Macdonald1,2,3

1Departments of Neurology, 2Molecular Physiology and Biophysics, 3Pharmacology, and 4Neurological Surgery, Vanderbilt University Medical Center, Nashville, Tennessee

Submitted 23 October 2007; accepted in final form 19 January 2008


 ABSTRACT
 
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Partial limbic seizures in rodents induced by pilocarpine progress from stages I–II (mouth and facial movements; head nodding) to stage III (forelimb clonus) and then progress rapidly to stages IV–V (generalized limbic seizures; rearing, and rearing with falling) followed by status epilepticus (SE). Although limbic seizures in rodents are terminated by benzodiazepines, a group of {gamma}-aminobutyric acid type A (GABAA)–receptor positive modulators, significant pharmacoresistance to benzodiazepines develops within minutes during SE. The alterations of GABAA-receptor function and allosteric modulation during development of SE are poorly understood. We induced seizures in juvenile rats by administration of lithium followed by pilocarpine, and whole cell recordings of miniature inhibitory postsynaptic currents (mIPSCs) were obtained from hippocampal dentate granule cells in brain slices. Compared with a sham-treated group, mIPSC amplitude was reduced and decay was accelerated at onset of the first occurrence of stage III (S3) seizures [S3(0)], resulting in a reduction in the total charge transfer at S3(0). Recovery of mIPSC amplitude and prolongation of mIPSC decay occurred 30 min after onset of S3 seizures [S3(30)]. The mIPSC frequency was not altered for S3(0) and S3(30) neurons compared with sham neurons. The net enhancement of total charge transfer by diazepam was smaller for S3(30) than that for sham and S3(0) neurons; however, the net reduction of total charge transfer by zinc was greater for S3(30) than that for sham and S3(0) neurons. These findings suggest that substantial plastic changes of GABAA-receptor function and allosteric modulation occur rapidly in neurons from juvenile animals during development of SE.


 INTRODUCTION
 
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Administration of pilocarpine in rodents induces progressive seizures that evolve from partial limbic seizures to generalized seizures and culminate in status epilepticus (SE) (Jones et al. 2002Go; Kapur and Macdonald 1997Go; Kubova et al. 2004Go). In the rodent pilocarpine model, electroencephalographic (EEG) studies demonstrated that seizures begin in the hippocampus (Turski et al. 1989Go) and that stage III seizures (S3, forelimb clonus) (Racine 1972Go) represent the transition from partial to generalized seizures (Jones et al. 2002Go). Substantial changes in neuronal excitability, receptor pharmacology, and receptor distribution have been demonstrated to occur early in SE, suggesting that significant molecular changes occur soon after the onset of generalized seizures. For example, SE at early stages can be effectively treated with benzodiazepines, but pharmacoresistance to benzodiazepines develops rapidly (Jones et al. 2002Go; Kapur and Macdonald 1997Go; Mazarati et al. 1998Go; Walton and Treiman 1988Go, 1991Go). Studies using the pilocarpine model of SE in juvenile animals demonstrated that pharmacoresistance to some anticonvulsants including benzodiazepines occurred within minutes after onset of S3 seizures (Jones et al. 2002Go). However, the mechanistic basis for the alteration of drug sensitivity during the development of SE remains unclear.

{gamma}-Aminobutyric acid type A (GABAA) receptors mediate the majority of inhibition in the mammalian brain, and two types of GABAergic inhibition have been described: phasic and tonic inhibition (Farrant and Nusser 2005Go; Mody and Pearce 2004Go). GABAA receptors are pentameric chloride ion channels formed by GABAA-receptor subunit subtypes selected from more than 16 subunit subtypes (Olsen and Macdonald 2002Go). It has been demonstrated that {alpha}β{gamma} and {alpha}β{delta} receptors are the predominant isoforms present in the brain (McKernan and Whiting 1996Go), primarily mediating phasic and tonic inhibition, respectively (Farrant and Nusser 2005Go; Saxena and Macdonald 1994Go; Stell et al. 2003Go). GABAA receptors are allosterically modulated in a subunit-dependent manner by a variety of structurally different positive and negative modulators, including benzodiazepines, barbiturates, neurosteroids, penicillin, and zinc (Olsen and Macdonald 2002Go). For example, benzodiazepines are positive modulators for {gamma}2 subunit–containing receptors and multiple domains of the {gamma}2 subunit are involved in their allosteric modulation (Boileau and Czajkowski 1999Go; Jones-Davis et al. 2005Go). In contrast, zinc is a negative modulator for {gamma}2-subunit–containing receptors, whose action may involve overlapping {gamma}2 subunit domains with those for benzodiazepines (Nagaya and Macdonald 2001Go). Based on these studies in recombinant receptors, it is expected that benzodiazepines and zinc may exert different effects on GABAergic phasic inhibition. Acute alterations of GABAA-receptor function and/or pharmacology have been observed shortly after SE onset (Goodkin et al. 2005Go; Kapur and Macdonald 1997Go; Naylor et al. 2005Go) and after development of epilepsy weeks or months after SE (Cohen et al. 2003Go; Leroy et al. 2004Go; Peng et al. 2004Go; Zhang et al. 2004Go). However, the alterations of GABAA-receptor function and allosteric modulation during development of SE are still poorly understood. By recording miniature inhibitory postsynaptic currents (mIPSCs) from hippocampal dentate granule cells in brain slices, we examined the alteration of mIPSC properties and modulation of mIPSC by diazepam and zinc at onset of the first occurrence of S3 seizures [S3(0)] and 30 min after onset of S3 seizures [S3(30)]. We demonstrated that mIPSC total charge transfer (mIPSC area) was reduced for S3(0) but enhanced for S3(30) neurons compared with sham neurons. In addition, we found that diazepam sensitivity was decreased and zinc sensitivity was increased at S3(30). These findings indicate that GABAA-receptor function and allosteric modulation undergo substantial plastic changes in neurons from juvenile animals during development of SE.


 METHODS
 
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Animals

Male Sprague–Dawley rats (Harlan, Indianapolis, IN) at 25–28 days old were used in the study. The rats were housed one per cage in a temperature-controlled animal facility on a 14-h/10-h light/dark cycle, with free access to food and tap water. Studies were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and the experimental protocol was approved by the Laboratory Animal Care and Use Committee of Vanderbilt University School of Medicine.

Induction of status epilepticus

Seizures were induced by intraperitoneal injection of 3 mEq/kg LiCl (Sigma–Aldrich, St. Louis, MO) followed 20–24 h later by 50 mg/kg pilocarpine hydrochloride (Sigma–Aldrich) (Jones et al. 2002Go). The animals exhibited five distinct stages of limbic seizures after pilocarpine administration, including mouth and facial movements (S1), head nodding (S2), forelimb clonus (S3), rearing (S4), and rearing and falling (S5) (Racine 1972Go). An EEG study suggested that S1 and S2 seizures were partial seizures and S4 and S5 seizures were generalized seizures. S3 seizures occurred at the transition stage for partial seizures progressing to generalized seizures (Jones et al. 2002Go). Once an animal began having S3 seizures, the seizures rapidly progressed to S4 or S4 followed by S5 seizures. As previously described (Jones et al. 2002Go), pilocarpine-induced seizures progressed from S1 to S4 or S5 seizures and were followed by a return to S2 seizures, which then progressed to S4 or S5 seizures again in a cycle recurring multiple times.

Since a previous behavioral study showed that the development of pharmacoresistance to some anticonvulsants including benzodiazepines occurred within minutes after onset of S3 seizures in juvenile rats (Jones et al. 2002Go), four groups of juvenile rats were used in the electrophysiological recordings to determine the mechanistic basis for benzodiazepine resistance and the alteration of GABAA-receptor function during the development of SE. The first group was treated with neither LiCl nor pilocarpine. The second group was treated only with LiCl (3 mEq/kg) and brain slices were prepared 20–24 h later. The third group [S3(0)] received LiCl followed by pilocarpine and brain slices were prepared at the onset of the first occurrence of S3 seizures. Because SE is traditionally defined as clinical or electrographic seizures lasting for ≥30 min (Kapur and Macdonald 1997Go), the fourth group [S3(30)] received LiCl followed by pilocarpine and brain slices were made 30 min after onset of the first occurrence of S3 seizures.

Electrophysiological recordings

Brain slices were prepared as previously described (Mathews and Diamond 2003Go; Zsiros and Maccaferri 2005Go). Since most anesthetics affect GABAA-receptor function, decapitation of juvenile rats was performed without anesthesia using methodology described in the approved institutional protocols. Brains were removed quickly and hemisected and then, using a Vibratome (Vibratome, St. Louis, MO), were sectioned into 400-µm coronal slices in ice-cold oxygenated solution, which was composed of (in mM) 1.25 NaH2PO4, 28 NaHCO3, 2.5 KCl, 0.5 CaCl2, 7 MgCl2, 7 glucose, 234 sucrose, 1 ascorbic acid, and 3 pyruvic acid. The slices were then incubated in the storage chamber at room temperature (19–23°C) for ≥1 h prior to transfer to the recording chamber. In both the storage and recording chambers, the slices were kept in artificial cerebrospinal fluid (ACSF) with the following composition (in mM): 119 NaCl, 2.5 KCl, 1.3 MgCl2, 2.5 CaCl2, 1 NaH2PO4, 26.2 NaHCO3, and 11 glucose. The ACSF was continually bubbled with 95% O2-5% CO2. During recordings, the slice was perfused with ACSF containing 40 µM D-2-amino-5-phosphopentanoic acid (AP5) and 10 µM 6-cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX) to block glutamate receptors. Tetrodotoxin (TTX, 1 µM) was also added to ACSF when miniature inhibitory postsynaptic currents (mIPSCs) were recorded. The pipettes for whole cell recording were pulled from thin-wall borosilicate glass (ID: 1.12 mm; OD: 1.5 mm; World Precision Instruments, Sarasota, FL) on a PP-830 Puller (Narishige, Tokyo, Japan). Recording pipette resistances were 4–6 M{Omega} when filled with an internal solution consisting of (in mM): 130 CsCl, 10 HEPES, 10 EGTA, 2 MgATP, 0.2 NaGTP, and 1 QX-314 (lidocaine N-ethyl bromide) (pH 7.4, 290 mOsm). All chemicals were purchased from Sigma–Aldrich.

Dentate gyrus granule cells were identified visually using an upright microscope (Olympus America, Woodbury, NY) equipped with infrared differential interference contrast video imaging. Cells were voltage clamped at –60 mV and whole cell recordings were obtained at room temperature (19–23°C) using an Axopatch-1D amplifier (Molecular Devices, Foster City, CA) and Digidata 1322A data acquisition system (Molecular Devices). Currents were low-pass filtered at 2 kHz, sampled at 10 kHz, and digitally stored on disk for off-line analysis. Series resistance (~10–18 M{Omega}) was not compensated, although it was checked frequently throughout the experiment, and recordings were terminated when series resistance increased by >20%.

Diazepam (in DMSO) and zinc chloride (both from Sigma–Aldrich) were prepared as stock solutions that were diluted with ACSF on the day of the experiment to the desired concentrations to make working solutions. The final concentration of DMSO in working solutions was <0.2%. The drugs were perfused using a peristaltic pump (Gilson, Middleton, WI), and a 5-min wash-in was allowed prior to mIPSC recordings.

Data analysis

Detection of individual mIPSCs was performed off-line using the Mini Analysis program (Synaptosoft, Fort Lee, NJ). The detection threshold was set at 15 pA. The mIPSCs were automatically detected by the program initially and then manually analyzed based on the criteria that only those events with a total rise time <1.5 ms were included in the analysis. Events with slower rise times may involve other complicated factors such as dendritic filtering or activation of extrasynaptic receptors that may confound interpretation of mIPSC kinetics (Kobayashi and Buckmaster 2003Go; McIntyre et al. 2002Go; Mody and Pearce 2004Go). The events within mIPSC area <50 fC (these events were too small to be considered mIPSCs) and overlapping mIPSCs were excluded from analysis. For each neuron, mIPSC kinetics and total charge transfer (mIPSC area) were analyzed on averaged events that were aligned by rise times. At least100 events were averaged for each neuron, and preliminary analysis indicated that further increase in the number of events did not significantly alter these parameters. The decay of the average mIPSCs was fitted using the formula of {sum}ane(–t/{tau}n), where a denotes the relative amplitude of the exponential component, {tau} represents the time constant, and n is the number of exponential components. Although the decay of some average mIPSCs could be fitted by only one exponential component, the majority of average mIPSCs were fitted by two exponential components. A weighted {tau} in the form of (a1{tau}1 + a2{tau}2)/(a1 + a2) was used to compare the rate of decay among different groups of neurons, where a1 and a2 are the relative amplitudes of the exponential components at time 0.

All mIPSC amplitudes, weighted decay time constants, and total charge transfer were reported as means ± SE. All mIPSC properties were compared using one-way ANOVA followed by Newman–Keuls multiple-comparison test among different neuronal groups. The paired Student's t-test was used to compare mIPSC properties prior to and after drug application. Differences were considered to be statistically significant at P < 0.05.


 RESULTS
 
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
The mIPSCs were recorded from hippocampal dentate granule cells in the presence of 40 µM AP5, 10 µM CNQX, and 1 µM TTX. Since the mIPSC properties were not significantly different between the first (treated with neither LiCl nor pilocarpine) and second (treated only with LiCl) group of rats, the data from these two groups of rats were pooled as a sham control group. The mIPSCs were recorded from slices obtained from 15 sham, 14 S3(0), and 15 S3(30) rats. Recordings were made from only one neuron in each slice and, for each neuron, only one drug (either diazepam or zinc) was applied to reduce the possible contamination by the other drug. Sometimes recordings were made from more than one slice from the same rat, but a minimum of four rats were used for each drug treatment. In these cases, the drug application system was adequately washed between recordings from different slices to minimize the drug contamination.

Seizure-induced alterations of mIPSC kinetics

The onsets of the first S3 seizures [S3(0)] occurred about 20 min after pilocarpine injection, and the S3(0) animals were killed at that time, whereas the S3(30) animals were killed 30 min after this point. We examined the mIPSC properties at both time points (Fig. 1, A and B). The mIPSC frequencies were not different among the sham (0.30 ± 0.05 Hz, n = 18), S3(0) (0.27 ± 0.04 Hz, n = 17), and S3(30) (0.31 ± 0.04 Hz, n = 20) neurons. However, compared with sham neurons, the amplitudes of mIPSCs were smaller for S3(0) neurons but were not altered for S3(30) neurons (Fig. 1, A and C). The mean mIPSC amplitude for S3(0) neurons (38.9 ± 1.8 pA) was smaller than that for either sham (46.9 ± 2.0 pA; P < 0.01) or S3(30) neurons (49.1 ± 2.0 pA; P < 0.01) (Fig. 1E). The mean amplitude of mIPSCs for S3(30) neurons was not different from that for sham neurons (Fig. 1E).


Figure 1
View larger version (27K):
[in this window]
[in a new window]

 
FIG. 1. Miniature inhibitory postsynaptic current (mIPSC) kinetics were altered for S3(0) and S3(30) neurons. A: examples of mIPSC traces recorded from a sham control rat (sham), a rat exhibiting onset of S3 seizures [S3(0)] and a rat with continued seizures 30 min after S3 seizures [S3(30)]. B: typical examples of average mIPSCs from sham, S3(0), or S3(30) neurons, showing the alterations of mIPSC decay in both S3(0) and S3(30) recordings. The dashed gray line indicates normalization of mIPSC amplitude in S3(0) and S3(30) recordings to sham recording; the gray traces were from the same sham neuron. C and D: the cumulative probability plots of mIPSC amplitude and decay time constant ({tau}) for neurons in B are presented. E: comparison of the mean mIPSC amplitude among sham, S3(0), and S3(30) neurons. The mean amplitude was significantly smaller for S3(0) neurons compared with that for sham and S3(30) neurons, but the mean amplitude for S3(30) neurons was not significantly different from that for sham neurons. F: comparison of the mean mIPSC weighted decay time constant ({tau}w) among sham, S3(0), and S3(30) neurons. The mean decay {tau}w was significantly smaller for S3(0) but significantly greater for S3(30) neurons compared with that for sham neurons. The mean decay {tau}w for S3(30) neurons was significantly greater than that for S3(0) neurons. G: comparison of total charge transfer (mIPSC area) among sham, S3(0), and S3(30) neurons. Compared with sham neurons, mIPSC area was significantly reduced for S3(0) neurons but was significantly increased for S3(30) neurons. The mIPSC area for S3(0) neurons was also significantly smaller than that for S3(30) neurons. Error bars represent the SE. *Significantly different from sham neurons at P < 0.05; **P < 0.01; ***P < 0.001. ++Significantly different from S3(0) neurons at P < 0.01; +++P < 0.001.

 
The decay of mIPSCs was differentially altered for S3(0) and S3(30) neurons compared with sham neurons (Fig. 1, B and D). The mean weighted decay time constant ({tau}w) for S3(0) neurons (29.8 ± 0.9 ms) was smaller than that for sham neurons (39.2 ± 1.2 ms; P < 0.05) (Fig. 1F). However, the mean weighted decay time constant for S3(30) neurons (48.3 ± 3.8 ms) was greater than that for sham neurons (P < 0.05). The mean weighted decay time constant for S3(30) neurons was also greater than that for S3(0) neurons (P < 0.001) (Fig. 1F).

GABAergic phasic inhibition is determined by mIPSC frequency, amplitude, and time course (i.e., decay) of synaptic events. Since mIPSC frequency was not different among the sham, S3(0), and S3(30) neurons, the total charge transfer (mIPSC area) was calculated to compare the magnitude of phasic inhibition among three groups of neurons. The mIPSC area was smaller for S3(0) neurons (1,188.4 ± 64.5 fC) than that for sham (1,683.5 ± 48.0 fC; P < 0.001) and S3(30) neurons (1,922.6 ± 114.2 fC; P < 0.001). The total charge transfer for S3(30) neurons was greater than that for sham neurons (P < 0.05) (Fig. 1G).

Modulation of mIPSC kinetics by diazepam for sham, S3(0), and S3(30) neurons

The effects of seizures on diazepam modulation of mIPSCs recorded from sham, S3(0), and S3(30) animals were determined (Fig. 2). Diazepam (1 µM) did not alter the mIPSC frequency for sham, S3(0), and S3(30) neurons, although it enhanced mIPSC amplitudes for these three groups of neurons (Fig. 2, A and C). Diazepam increased the mean mIPSC amplitude of sham neurons from 45.3 ± 3.3 to 66.3 ± 4.3 pA (n = 7, P < 0.01). The mean mIPSC amplitude for S3(0) neurons was augmented from 40.9 ± 3.0 to 61.9 ± 3.1 pA by diazepam (n = 5, P < 0.01). For S3(30) neurons, diazepam enhanced the mIPSC amplitude compared with that of controls (50.1 ± 2.3 vs. 58.7 ± 2.1 pA; n = 8, P < 0.01). However, the net increase (%) in mIPSC amplitude by diazepam was not significantly different among the sham, S3(0), and S3(30) neurons.


Figure 2
View larger version (27K):
[in this window]
[in a new window]

 
FIG. 2. Modulation of mIPSC kinetics by diazepam for sham, S3(0), and S3(30) neurons. A: typical examples of average mIPSCs and cumulative probability plots prior to and after application of diazepam (DZP, 1 µM) for sham, S3(0), and S3(30) neurons, demonstrating the changes of mIPSC amplitudes induced by this drug. The gray traces indicate the control currents; the black traces denote the currents after drug application. B: for the same neurons in A, the control mIPSC amplitudes were normalized to those after drug application to demonstrate the alterations of mIPSC decay induced by DZP. The decay alterations were also shown using cumulative probability plots. C: comparison of the mean net increase in mIPSC amplitude by DZP among sham, S3(0), and S3(30) neurons. The percentage (%) increase in mIPSC amplitude was not different among the 3 groups of neurons. D: comparison of the mean net increase in mIPSC weighted decay time constant ({tau}w) by DZP among sham, S3(0), and S3(30) neurons. The % increase in decay {tau}w was significantly reduced for S3(30) neurons compared with S3(0) neurons. Compared with sham neurons, the % increase in decay {tau}w was not significantly altered for S3(0) and S3(30) neurons. E: comparison of the mean net increase in total charge transfer (mIPSC area) by DZP among sham, S3(0), and S3(30) neurons. The mean net increase in mIPSC area by diazepam was significantly reduced for S3(30) neurons compared with that for both sham and S3(0) neurons. The mean net increase in mIPSC area for sham neurons was not significantly different from that for S3(0) neurons. Error bars represent the SE. *Significantly different from sham neurons at P < 0.05. +Significantly different from S3(0) neurons at P < 0.05; ++P < 0.01.

 
Diazepam also prolonged the mIPSC decay for sham, S3(0), and S3(30) neurons (Fig. 2, B and D). The mean mIPSC weighted decay time constant for sham neurons was increased from 40.0 ± 1.9 to 58.8 ± 3.6 ms by diazepam (P < 0.001). Diazepam increased the mean weighted decay time constant from 31.9 ± 2.3 to 54.7 ± 1.5 ms for S3(0) neurons (P < 0.001) and from 45.3 ± 4.0 to 58.0 ± 2.1 ms for S3(30) neurons (P < 0.01). However, the net increase in mIPSC weighted decay time constant by diazepam was smaller for S3(30) neurons (33.5 ± 9.2%) than that for S3(0) neurons (74.2 ± 10.1%) (P < 0.05), although no significant difference was observed compared with sham with either S3(0) or S3(30) neurons.

The total charge transfer (mIPSC area) was increased by diazepam for sham, S3(0), and S3(30) neurons (Fig. 2E). Diazepam increased the mean mIPSC area from 1,661.7 ± 83.3 to 3,338.0 ± 329.1 fC for sham neurons (P < 0.01). The mean mIPSC area was increased by diazepam from 1,318.5 ± 121.7 to 2,960.3 ± 136.7 fC for S3(0) neurons (P < 0.01) and from 2,086.5 ± 221.5 to 3,003.8 ± 146.2 fC for S3(30) neurons (P < 0.001). The net increase in mIPSC area by diazepam was smaller for S3(30) neurons (51.4 ± 11.0%) than that for sham (100.6 ± 15.3%) (P < 0.05) and S3(0) neurons (131.7 ± 21.6%) (P < 0.01). The net increase in mIPSC area for sham neurons was not significantly different from that for S3(0) neurons (Fig. 2E).

Modulation of mIPSC kinetics by zinc for sham, S3(0), and S3(30) neurons

The effects of seizures on zinc inhibition of mIPSCs recorded from sham, S3(0), and S3(30) animals were determined (Fig. 3). Zinc (300 µM) did not affect mIPSC frequency but decreased the mIPSC amplitudes for sham, S3(0), and S3(30) neurons (Fig. 3, A and C). The mean mIPSC amplitude was reduced by zinc from 51.2 ± 3.2 to 41.8 ± 2.3 pA for sham neurons (n = 7, P < 0.05). Zinc also inhibited mIPSC amplitude from 39.8 ± 2.7 to 36.3 ± 1.7 pA for S3(0) neurons (n = 9, P < 0.05) and from 49.2 ± 3.3 to 33.9 ± 2.4 pA for S3(30) neurons (n = 9, P < 0.001). The net decrease in mIPSC amplitude by zinc was greater for S3(30) neurons (30.4 ± 3.2%) than that for S3(0) neurons (7.4 ± 3.3%) (P < 0.001). The net decrease in mIPSC amplitude for sham neurons (17.7 ± 3.7%) was greater than that for S3(0) (P < 0.05) but smaller than that for S3(30) neurons (P < 0.05).


Figure 3
View larger version (27K):
[in this window]
[in a new window]

 
FIG. 3. Modulation of mIPSC kinetics by zinc for sham, S3(0), and S3(30) neurons. A: typical examples of average mIPSCs and cumulative probability plots prior to and after application of zinc (Zn2+, 300 µM) for sham, S3(0), and S3(30) neurons, demonstrating the changes of mIPSC amplitudes induced by this drug. The gray traces indicate the control currents; the black traces denote the currents after drug application. B: for the same neurons in A, the mIPSC amplitudes after drug application were normalized to those for control currents to demonstrate the alterations of mIPSC decay induced by zinc. The decay alterations are also shown using cumulative probability plots. C: comparison of the mean net decrease in mIPSC amplitude by zinc among sham, S3(0), and S3(30) neurons. The % decrease in mIPSC amplitude was significantly greater for S3(30) neurons compared with that for S3(0) neurons. The % decrease in mIPSC amplitude for sham neurons was significantly different from that for S3(0) and S3(30) neurons. D: comparison of the mean net decrease in mIPSC weighted decay time constant ({tau}w) by zinc among sham, S3(0), and S3(30) neurons. The % decrease in decay {tau}w was significantly greater for S3(30) neurons compared with that for sham and S3(0) neurons. The % decrease in decay {tau}w was not significant between sham and S3(0) neurons. E: comparison of the mean net decrease in total charge transfer (mIPSC area) by zinc among sham, S3(0), and S3(30) neurons. The mean net decrease in mIPSC area by zinc was significantly greater for S3(30) than that for S3(0) neurons. The mean net decrease in mIPSC area was significantly smaller for S3(0) but was significantly greater for S3(30) neurons compared with that for sham neurons. Error bars represent the SE. *Significantly different from sham neurons at P < 0.05; **P < 0.01. +++Significantly different from S3(0) neurons at P < 0.001.

 
Zinc accelerated the mIPSC decay for sham and S3(30) neurons but did not alter that for S3(0) neurons (Fig. 3, B and D). Zinc reduced the mean weighted decay time constant from 37.5 ± 1.9 to 32.0 ± 2.5 ms for sham neurons (P < 0.05). For S3(30) neurons, the mean weighted decay time constant was decreased from 46.7 ± 4.9 to 31.1 ± 1.6 ms by zinc (P < 0.01). Zinc did not significantly change the mean weighted decay time constant for S3(0) neurons. The net decrease in weighted decay time constant by zinc was greater for S3(30) neurons (29.3 ± 5.0%) than that for either sham (14.4 ± 5.5%; P < 0.05) or S3(0) neurons (1.5 ± 2.0%; P < 0.001). The net decrease in mean weighted decay time constant was not significantly different between sham and S3(0) neurons.

The total charge transfer (mIPSC area) was reduced by zinc for sham, S3(0), and S3(30) neurons (Fig. 3E). Zinc decreased mean mIPSC area from 1,705.7 ± 89.9 to 1,287.3 ± 81.0 fC for sham neurons (P < 0.01). The mean mIPSC area was also reduced by zinc from 1,182.2 ± 89.8 to 1,035.7 ± 56.0 fC for S3(0) neurons (P < 0.05) and from 1,818.9 ± 131.9 to 1,043.6 ± 54.8 fC for S3(30) neurons (P < 0.001). The net decrease in mIPSC area by zinc was greater for S(30) neurons (41.1 ± 3.5%) than that for S3(0) neurons (10.9 ± 3.3%; P < 0.001). The net decrease in mIPSC area for sham neurons (24.0 ± 4.2%) was different from that for S3(0) (P < 0.05) and S3(30) neurons (P < 0.01) (Fig. 3E).


 DISCUSSION
 
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
In the present study, we report that GABAA-receptor function was altered acutely during the evolution of status epilepticus. Both the amplitude and the weighted decay time constant of mIPSCs were altered as seizures progressed from partial to generalized seizures, resulting in less total charge transfer per synaptic event. Pharmacoresistance to benzodiazepines, as determined by the effect of diazepam on mean total charge transfer, developed by 30 min after onset of S3 seizures. The net increase in mIPSC weighted decay time constant by diazepam was smaller for S3(30) than that for S3(0) neurons and the net increase in mIPSC area was smaller for S3(30) than that for sham and S3(0) neurons. The net decreases in both amplitude and weighted decay time constant by zinc were greater for S3(30) neurons than those for sham and S3(0) neurons. The net decrease in mIPSC area was smaller for S3(0) and greater for S3(30) neurons compared with that sham neurons. These data demonstrated that significant plastic changes of GABAA-receptor function and allosteric modulation occurred rapidly in neurons from juvenile animals during development of SE.

Plastic changes of GABAA-receptor function during development of SE

A previous EEG study suggested that pilocarpine-induced seizures develop from partial to generalized seizures culminating in SE (Jones et al. 2002Go). Both mIPSC amplitude and weighted decay time constant were significantly reduced at S3(0), the transition point from partial to generalized seizures, leading to a reduction of total charge transfer compared with sham neurons. Associated with this compromised GABAA-receptor function at S3(0), a previous behavioral study demonstrated that progression to S4 or S4 followed by S5 seizures was rapid once S3 was reached (Jones et al. 2002Go). It would be interesting to know whether the reduction of GABAergic phasic inhibition contributes to seizure spread and generalization. The mIPSC amplitude recovered and decay was prolonged for S3(30) neurons, resulting in an increased total charge transfer compared with that for sham neurons. Pilocarpine-induced seizures progressed from S1 to S4 or S5 seizures and were followed by a return to S2 seizures, which then progressed to S4 or S5 seizures again in a cycle recurring multiple times (Jones et al. 2002Go). It would be interesting to know whether the enhanced GABAergic function contributed to the periodic reduction of seizure severity. The weighted decay time constant of mIPSCs in the present study was larger than previously reported values at room temperature (McIntyre et al. 2002Go; Perrais and Ropert 1999Go). However, our recordings were performed at a temperature range (19–23°C) lower than that of the above-cited studies (22–26°C). In addition, IPSC decay can be affected by other factors such as the phosphorylation state of the GABAA receptors (Jones and Westbrook 1997Go). All these factors may have contributed to the slower mIPSC decay in this study.

The alterations of GABAergic phasic inhibition during prolonged acute seizures may be related to short-term changes of GABAA receptors such as posttranslational modifications, receptor trafficking, and receptor endocytosis. Rapid internalization of GABAA receptors has been observed at 1 h after SE in a pilocarpine model (Naylor et al. 2005Go) and as early as 10 min in an in vitro model of SE (Goodkin et al. 2005Go). Thus the functional alterations of GABAA receptors in the current study were likely due to receptor internalization. The mIPSC amplitude was not altered 30 min after S3 seizures compared with sham neurons. A parsimonious explanation is that although surface GABAA-receptor number was reduced by prolonged seizures, the receptor efficacy might have been enhanced by some factors. Although there are likely to be additional mechanisms affecting GABAergic inhibition during prolonged seizures (e.g., changes in chloride gradient), the changes in mIPSC kinetics we observed were more consistent with alterations of GABAA receptors. Weeks or months after SE, spontaneous recurrent seizures (epilepsy) could develop in these rats, and GABAA-receptor functional alterations have been reported. It was shown that GABAA-receptor–mediated inhibition was reduced in the epileptic rats (Isokawa 1996Go; Kobayashi and Buckmaster 2003Go). Several other studies, interestingly, demonstrated that mIPSC amplitude was enhanced in these animals (Cohen et al. 2003Go; Gavrilovici et al. 2006Go; Leroy et al. 2004Go; Nusser et al. 1998Go; Sun et al. 2007Go). In contrast to the possible mechanisms for the acute changes we observed, alterations of GABAergic phasic inhibition during epilepsy are likely related to long-term changes in GABAA-receptor expression and/or function such as regulation of receptor gene expression and degradation or synthesis of multiple receptor subunit proteins.

Seizure-induced alterations of GABAA-receptor allosteric modulation

The net increase in total charge transfer by diazepam was significantly smaller for S3(30) than that for sham and S3(0) neurons, suggesting that the sensitivity of GABAA receptors to benzodiazepines was decreased 30 min after onset of S3 seizures. This finding is consistent with our previous report using isolated, dissociated dentate granule cells that diazepam sensitivity was reduced after prolonged seizures (Kapur and Macdonald 1997Go), supporting the idea that a reduction in allosteric modulation of GABAA receptors by diazepam may contribute to the rapid diazepam pharmacoresistance observed in behavioral studies (Jones et al. 2002Go; Walton and Treiman 1988Go). Although the underlying cellular and molecular changes of GABAA receptors in the current study may be different from those that occur during epilepsy, the pharmacoresistance to diazepam was also observed in epileptic rats weeks or months after SE (Cohen et al. 2003Go; Leroy et al. 2004Go).

Diazepam consistently augmented mIPSC amplitude in the present study, which is in contrast with several previous reports that benzodiazepines prolonged the mIPSC decay but did not enhance amplitudes in normal animals (Cohen et al. 2003Go; Leroy et al. 2004Go; Poncer et al. 1996Go). Diazepam modulation of mIPSC amplitude may be age dependent; potentiation of GABA-evoked currents (Zhang et al. 2004Go) and mIPSC amplitudes (Cohen et al. 2000Go; Defazio and Hablitz 1998Go; Hajos et al. 2000Go; Nusser et al. 1997Go; Perrais and Ropert 1999Go) has been observed in juvenile neurons including hippocampal dentate granule cells. In addition, the potentiating effect of diazepam may also be temperature dependent (Perrais and Ropert 1999Go).

The net change in total charge transfer by zinc was significantly decreased for S3(0) compared with that for sham neurons, suggesting that zinc sensitivity was reduced for S3(0) neurons. The reduction of zinc sensitivity during development of SE was reported previously in hippocampal and cortical neurons (Banerjee et al. 1999Go; Kapur and Macdonald 1997Go). The net change evoked by zinc on total charge transfer was significantly greater for S3(30) neurons compared with that for sham and S3(0) neurons, demonstrating that the sensitivity of GABAA receptors to zinc was significantly increased 30 min after onset of S3 seizures. Interestingly, it has been demonstrated that GABAA -receptor sensitivity to zinc was significantly increased in epileptic rats (Cohen et al. 2003Go) and in amygdala kindled rats (Buhl et al. 1996Go). A recent study demonstrated that pilocarpine or pilocarpine-induced seizures did not result in changes of distribution of endogenous zinc in hippocampus ≤2 h after pilocarpine injection (Noyan et al. 2007Go). Therefore the zinc sensitivity alterations we observed for S3(0) and S3(30) neurons were unlikely to be caused by endogenous zinc distribution changes but more likely to be due to seizure-evoked alteration of GABAA-receptor allosteric modulation.

Zinc had no effects on mIPSC amplitude and decay of dentate granule cells from normal adult animals (Buhl et al. 1996Go; Cohen et al. 2003Go; Hollrigel and Soltesz 1997Go). However, it inhibited the mIPSC amplitude and accelerated the decay in juvenile neurons including dentate granule cells (Defazio and Hablitz 1998Go; Hollrigel and Soltesz 1997Go). Consistent with this, we found that zinc reduced mIPSC total charge transfer in normal juvenile rats. This age-dependent effect of zinc on phasic currents is reminiscent of that of diazepam. It is not known whether these two phenomena share similar cellular and/or molecular mechanisms.

The molecular mechanisms underlying the altered allosteric modulation of GABAergic phasic currents by diazepam and zinc during acute seizures are poorly understood. One possibility is alteration of surface GABAA-receptor subunit composition considering that several receptor isoforms exhibit differential sensitivity to benzodiazepines and zinc (Olsen and Macdonald 2002Go). In the chronic epilepsy model, multiple subunit mRNA and/or protein changes have been observed days or weeks after SE (Brooks-Kayal et al. 1998Go; Peng et al. 2004Go). It is interesting to note that the alterations of phasic current sensitivity to diazepam and zinc during acute seizures in the present study were similarly observed in epileptic rats (Buhl et al. 1996Go; Cohen et al. 2003Go; Leroy et al. 2004Go). As mentioned earlier, the alterations of allosteric modulation during acute seizures may result from short-term changes in GABAA receptors, whereas those that occur once epilepsy is established may result from long-term changes in GABAA receptors. It seems that the outcomes of GABAA-receptor changes with these two scenarios sometimes may be similar. Further experiments are needed to explore the underlying mechanisms.

It is also possible that altered sensitivity to diazepam or zinc may be contributed by phosphorylation or dephosphorylation of GABAA receptors. Allosteric modulation of GABAA receptors by benzodiazepines was altered by PKC phosphorylation in vitro (Leidenheimer et al. 1993Go). It was also reported that GABAA-receptor subunit protein dephosphorylation occurred rapidly after seizures (Sanchez et al. 2005Go) and a reduction of CaM kinase II activity was associated with amygdala kindling as well as SE (Singleton et al. 2005Go; Wasterlain and Farber 1984Go).

In summary, we demonstrated that significant plastic changes of both GABAA-receptor function and allosteric modulation rapidly occurred in neurons from juvenile animals during development of SE.


 GRANTS
 
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
This work was supported by National Institute of Neurological Disorders and Stroke Grant NS-39479 to R. L. Macdonald.


 ACKNOWLEDGMENTS
 
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
We thank Dr. Gianmaria Maccaferri for technical assistance.


 FOOTNOTES
 
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Address for reprint requests and other correspondence: H.-J. Feng, Department of Neurology, Vanderbilt University Medical Center, 6140 Medical Research Building III, 465 21st Ave, South., Nashville, TN 37232-8552 (E-mail: huajun.feng{at}vanderbilt.edu)


 REFERENCES
 
 TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 GRANTS
 ACKNOWLEDGMENTS
 REFERENCES
 
Banerjee PK, Olsen RW, Snead OC 3rd. Zinc inhibition of {gamma}-aminobutyric acidA receptor function is decreased in the cerebral cortex during pilocarpine-induced status epilepticus. J Pharmacol Exp Ther 291: 361–366, 1999.[Abstract/Free Full Text]

Boileau AJ, Czajkowski C. Identification of transduction elements for benzodiazepine modulation of the GABAA receptor: three residues are required for allosteric coupling. J Neurosci 19: 10213–10220, 1999.[Abstract/Free Full Text]

Brooks-Kayal AR, Shumate MD, Jin H, Rikhter TY, Coulter DA. Selective changes in single cell GABAA receptor subunit expression and function in temporal lobe epilepsy. Nat Med 4: 1166–1172, 1998.[CrossRef][Web of Science][Medline]

Buhl EH, Otis TS, Mody I. Zinc-induced collapse of augmented inhibition by GABA in a temporal lobe epilepsy model. Science 271: 369–373, 1996.[Abstract]

Cohen AS, Lin DD, Coulter DA. Protracted postnatal development of inhibitory synaptic transmission in rat hippocampal area CA1 neurons. J Neurophysiol 84: 2465–2476, 2000.[Abstract/Free Full Text]

Cohen AS, Lin DD, Quirk GL, Coulter DA. Dentate granule cell GABAA receptors in epileptic hippocampus: enhanced synaptic efficacy and altered pharmacology. Eur J Neurosci 17: 1607–1616, 2003.[CrossRef][Web of Science][Medline]

Defazio T, Hablitz JJ. Zinc and zolpidem modulate mIPSCs in rat neocortical pyramidal neurons. J Neurophysiol 80: 1670–1677, 1998.[Abstract/Free Full Text]

Farrant M, Nusser Z. Variations on an inhibitory theme: phasic and tonic activation of GABAA receptors. Nat Rev Neurosci 6: 215–229, 2005.[CrossRef][Web of Science][Medline]

Gavrilovici C, D'Alfonso S, Dann M, Poulter MO. Kindling-induced alterations in GABAA receptor-mediated inhibition and neurosteroid activity in the rat piriform cortex. Eur J Neurosci 24: 1373–1384, 2006.[CrossRef][Web of Science][Medline]

Goodkin HP, Yeh JL, Kapur J. Status epilepticus increases the intracellular accumulation of GABAA receptors. J Neurosci 25: 5511–5520, 2005.[Abstract/Free Full Text]

Hajos N, Nusser Z, Rancz EA, Freund TF, Mody I. Cell type- and synapse-specific variability in synaptic GABAA receptor occupancy. Eur J Neurosci 12: 810–818, 2000.[CrossRef][Web of Science][Medline]

Hollrigel GS, Soltesz I. Slow kinetics of miniature IPSCs during early postnatal development in granule cells of the dentate gyrus. J Neurosci 17: 5119–5128, 1997.[Abstract/Free Full Text]

Isokawa M. Decrement of GABAA receptor-mediated inhibitory postsynaptic currents in dentate granule cells in epileptic hippocampus. J Neurophysiol 75: 1901–1908, 1996.[Abstract/Free Full Text]

Jones DM, Esmaeil N, Maren S, Macdonald RL. Characterization of pharmacoresistance to benzodiazepines in the rat Li-pilocarpine model of status epilepticus. Epilepsy Res 50: 301–312, 2002.[CrossRef][Web of Science][Medline]

Jones MV, Westbrook GL. Shaping of IPSCs by endogenous calcineurin activity. J Neurosci 17: 7626–7633, 1997.[Abstract/Free Full Text]

Jones-Davis DM, Song L, Gallagher MJ, Macdonald RL. Structural determinants of benzodiazepine allosteric regulation of GABAA receptor currents. J Neurosci 25: 8056–8065, 2005.[Abstract/Free Full Text]

Kapur J, Macdonald RL. Rapid seizure-induced reduction of benzodiazepine and Zn2+ sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci 17: 7532–7540, 1997.[Abstract/Free Full Text]

Kobayashi M, Buckmaster PS. Reduced inhibition of dentate granule cells in a model of temporal lobe epilepsy. J Neurosci 23: 2440–2452, 2003.[Abstract/Free Full Text]

Kubova H, Mares P, Suchomelova L, Brozek G, Druga R, Pitkanen A. Status epilepticus in immature rats leads to behavioural and cognitive impairment and epileptogenesis. Eur J Neurosci 19: 3255–3265, 2004.[CrossRef][Web of Science][Medline]

Leidenheimer NJ, Whiting PJ, Harris RA. Activation of calcium-phospholipid-dependent protein kinase enhances benzodiazepine and barbiturate potentiation of the GABAA receptor. J Neurochem 60: 1972–1975, 1993.[CrossRef][Web of Science][Medline]

Leroy C, Poisbeau P, Keller AF, Nehlig A. Pharmacological plasticity of GABAA receptors at dentate gyrus synapses in a rat model of temporal lobe epilepsy. J Physiol 557: 473–487, 2004.[Abstract/Free Full Text]

Mathews GC, Diamond JS. Neuronal glutamate uptake contributes to GABA synthesis and inhibitory synaptic strength. J Neurosci 23: 2040–2048, 2003.[Abstract/Free Full Text]

Mazarati AM, Baldwin RA, Sankar R, Wasterlain CG. Time-dependent decrease in the effectiveness of antiepileptic drugs during the course of self-sustaining status epilepticus. Brain Res 814: 179–185, 1998.[CrossRef][Web of Science][Medline]

McIntyre DC, Hutcheon B, Schwabe K, Poulter MO. Divergent GABAA receptor-mediated synaptic transmission in genetically seizure-prone and seizure-resistant rats. J Neurosci 22: 9922–9931, 2002.[Abstract/Free Full Text]

McKernan RM, Whiting PJ. Which GABAA-receptor subtypes really occur in the brain? Trends Neurosci 19: 139–143, 1996.[CrossRef][Web of Science][Medline]

Mody I, Pearce RA. Diversity of inhibitory neurotransmission through GABAA receptors. Trends Neurosci 27: 569–575, 2004.[CrossRef][Web of Science][Medline]

Nagaya N, Macdonald RL. Two {gamma}2L subunit domains confer low Zn2+ sensitivity to ternary GABAA receptors. J Physiol 532: 17–30, 2001.[Abstract/Free Full Text]

Naylor DE, Liu H, Wasterlain CG. Trafficking of GABAA receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus. J Neurosci 25: 7724–7733, 2005.[Abstract/Free Full Text]

Noyan B, Jensen MS, Danscher G. The lack of effects of zinc and nitric oxide in initial state of pilocarpine-induced seizures. Seizure 16: 410–416, 2007.[CrossRef][Web of Science][Medline]

Nusser Z, Cull-Candy S, Farrant M. Differences in synaptic GABAA receptor number underlie variation in GABA mini amplitude. Neuron 19: 697–709, 1997.[CrossRef][Web of Science][Medline]

Nusser Z, Hajos N, Somogyi P, Mody I. Increased number of synaptic GABAA receptors underlies potentiation at hippocampal inhibitory synapses. Nature 395: 172–177, 1998.[CrossRef][Medline]

Olsen RW, Macdonald RL. GABAA receptor complex: structure and function. In: Glutamate and GABA Receptors and Transporters: Structure, Function and Pharmacology, edited by Egebjerg J, Schousboe A, Krogsgaard-Larsen P. London: Taylor & Francis, 2002, p. 202–235.

Peng Z, Huang CS, Stell BM, Mody I, Houser CR. Altered expression of the {delta} subunit of the GABAA receptor in a mouse model of temporal lobe epilepsy. J Neurosci 24: 8629–8639, 2004.[Abstract/Free Full Text]

Perrais D, Ropert N. Effect of zolpidem on miniature IPSCs and occupancy of postsynaptic GABAA receptors in central synapses. J Neurosci 19: 578–588, 1999.[Abstract/Free Full Text]

Poncer JC, Durr R, Gahwiler BH, Thompson SM. Modulation of synaptic GABAA receptor function by benzodiazepines in area CA3 of rat hippocampal slice cultures. Neuropharmacology 35: 1169–1179, 1996.[CrossRef][Web of Science][Medline]

Racine RJ. Modification of seizure activity by electrical stimulation. II. Motor seizure. Electroencephalogr Clin Neurophysiol 32: 281–294, 1972.[CrossRef][Web of Science][Medline]

Sanchez RM, Dai W, Levada RE, Lippman JJ, Jensen FE. AMPA/kainate receptor-mediated downregulation of GABAergic synaptic transmission by calcineurin after seizures in the developing rat brain. J Neurosci 25: 3442–3451, 2005.[Abstract/Free Full Text]

Saxena NC, Macdonald RL. Assembly of GABAA receptor subunits: role of the {delta} subunit. J Neurosci 14: 7077–7086, 1994.[Abstract]

Singleton MW, Holbert WH 2nd, Lee AT, Bracey JM, Churn SB. Modulation of CaM kinase II activity is coincident with induction of status epilepticus in the rat pilocarpine model. Epilepsia 46: 1389–1400, 2005.[CrossRef][Medline]

Stell BM, Brickley SG, Tang CY, Farrant M, Mody I. Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by {delta} subunit-containing GABAA receptors. Proc Natl Acad Sci USA 100: 14439–14444, 2003.[Abstract/Free Full Text]

Sun C, Mtchedlishvili Z, Erisir A, Kapur J. Diminished neurosteroid sensitivity of synaptic inhibition and altered location of the {alpha}4 subunit of GABAA receptors in an animal model of epilepsy. J Neurosci 27: 12641–12650, 2007.[Abstract/Free Full Text]

Turski L, Ikonomidou C, Turski WA, Bortolotto ZA, Cavalheiro EA. Review: cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse 3: 154–171, 1989.[CrossRef][Web of Science][Medline]

Walton NY, Treiman DM. Response of status epilepticus induced by lithium and pilocarpine to treatment with diazepam. Exp Neurol 101: 267–275, 1988.[CrossRef][Web of Science][Medline]

Walton NY, Treiman DM. Motor and electroencephalographic response of refractory experimental status epilepticus in rats to treatment with MK-801, diazepam, or MK-801 plus diazepam. Brain Res 553: 97–104, 1991.[CrossRef][Web of Science][Medline]

Wasterlain CG, Farber DB. Kindling alters the calcium/calmodulin-dependent phosphorylation of synaptic plasma membrane proteins in rat hippocampus. Proc Natl Acad Sci USA 81: 1253–1257, 1984.[Abstract/Free Full Text]

Zhang G, Raol YH, Hsu FC, Coulter DA, Brooks-Kayal AR. Effects of status epilepticus on hippocampal GABAA receptors are age-dependent. Neuroscience 125: 299–303, 2004.[CrossRef][Web of Science][Medline]

Zsiros V, Maccaferri G. Electrical coupling between interneurons with different excitable properties in the stratum lacunosum-moleculare of the juvenile CA1 rat hippocampus. J Neurosci 25: 8686–8695, 2005.[Abstract/Free Full Text]





This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
99/3/1285    most recent
01180.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feng, H.-J.
Right arrow Articles by Macdonald, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feng, H.-J.
Right arrow Articles by Macdonald, R. L.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the The American Physiological Society.